Found: 6
Select item for more details and to access through your institution.
Optimizing Nanopore sequencing-based detection of structural variants enables individualized circulating tumor DNA-based disease monitoring in cancer patients.
- Published in:
- Genome Medicine, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13073-021-00899-7
- By:
- Publication type:
- Article
Ovarian Cancer Cell Line Panel (OCCP): Clinical Importance of In Vitro Morphological Subtypes.
- Published in:
- PLoS ONE, 2014, v. 9, n. 9, p. 1, doi. 10.1371/journal.pone.0103988
- By:
- Publication type:
- Article
TP53 Mutations in Serum Circulating Cell-Free Tumor DNA As Longitudinal Biomarker for High-Grade Serous Ovarian Cancer.
- Published in:
- Biomolecules (2218-273X), 2020, v. 10, n. 3, p. 415, doi. 10.3390/biom10030415
- By:
- Publication type:
- Article
High‐throughput isolation of circulating tumor DNA: a comparison of automated platforms.
- Published in:
- Molecular Oncology, 2019, v. 13, n. 2, p. 392, doi. 10.1002/1878-0261.12415
- By:
- Publication type:
- Article
Somatic mutation detection using various targeted detection assays in paired samples of circulating tumor DNA, primary tumor and metastases from patients undergoing resection of colorectal liver metastases.
- Published in:
- Molecular Oncology, 2016, v. 10, n. 10, p. 1575, doi. 10.1016/j.molonc.2016.10.001
- By:
- Publication type:
- Article
LRG1 mRNA expression in breast cancer associates with PIK3CA genotype and with aromatase inhibitor therapy outcome.
- Published in:
- Molecular Oncology, 2016, v. 10, n. 8, p. 1363, doi. 10.1016/j.molonc.2016.07.004
- By:
- Publication type:
- Article